EXDI Exactus Inc

Exactus Inc. Provides Hemp Farm Update and Will Begin Taking Orders for Triple A Top Flower

Exactus Inc. Provides Hemp Farm Update and Will Begin Taking Orders for Triple A Top Flower

DELRAY BEACH, Fla., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB:EXDI) (the “Company”), a farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that it is on track to exceed its initial estimates of 20,000 lbs of top flower and will begin taking orders.

Emiliano Aloi, President and Chief Executive Officer of Exactus said, “Our farming efforts and our team’s relentless pursuit of quality are beginning to show. With the near completion of our on-site drying and packaging infrastructure, we will be able to deliver premium hemp flower products straight from the farm.”

Compliance testing has been performed on all the fields by ODA appointed personnel, resulting in a 100% pass rate of tested samples.

Shea McInvale, Manager of Exactus One World, said, “It was a good day, our crop is healthy and every test returned by the ODA passed with flying colors. Our highest THC read was 0.1%, which is 1/3rd of the compliance limits set by the U.S. Agricultural Improvement Act of 2018.”

The Company will begin harvesting the top flower on September 15th and will continue to harvest through November.

Delivery of 2019 flower products will begin in October following the drying, processing and packaging.

The company is pleased to offer the following strains of top flower for distribution:

Suver Haze®: Suver Haze has the most unique and intoxicating nose in the CBD line; nearly equal parts farnesene and beta-caryophyllene as the co-dominant terpenes create an exotic sour apple flavor. This variety is known for open flower structure, resulting in record-setting resin content.

Special Sauce: The flagship line, containing exotic astringent berry smells, beautiful pink pistils, and some of the highest oil returns of any industrial hemp on the planet. The strain’s true F1 progeny are testaments to what is possible with terpenes. Flowers are smaller than others, but end up very dense and coated in glistening resin. This is a top-seller in the international trimmed flower market and peerless for full spectrum oil extraction. Special Sauce possesses the highest average CBD content of all lines and is a true gift to smell.

Lifter: Carries a farnesene dominant terpene profile, with incredible vegetative vigor and grows like a bush with rock-hard flowers, creating vigorous bushy, upright growth patterns. The flavor is very sought after by consumers.

Hawaiian Haze®: A cross-breed between a specially selected Neville’s Haze male specimen and the widely popular ACDC, Hawaiian Haze emanates truly special flavors that used to emanate from imported Hawaiian flowers (beta-carypholene and humulene are key secondary and tertiary terpenes). Hawaiian Haze brings farmers unique equatorially-inspired, long season flavor with large yielding, modern hybrid flower structures. This has been among the most popular flower products since its first field trials in 2017.

Sour Space Candy: The CBD-dominant Sour Tsunami cut used in this cross has the strongest stalk of any plant we have grown and sports a unique, terpinolene-forward flavor similar to GG4 and the Sour Diesel / Chem / OG lines. This variety yields a unique flavor profile reminiscent of sour candy from outer space. Growers will be rewarded with full, golf ball-sized flowers that will stay intact, even when subjected to large-scale machine trimming.

For indications of interest, please contact Nicolas Cavo, VP of Sales at for more information.

To learn more about Exactus, Inc., visit the website at .

About Exactus:

Exactus Inc. is dedicated to introducing hemp-derived phytocannabinoid products into mainstream consumer markets. The Company has made investments in farming and has over 200 acres of CBD-rich hemp in Southwest Oregon. The Company is introducing a range of consumer brands, such as Green Goddess Extracts, Phenologie, Paradise CBD and Exactus. Hemp is a legal type of cannabis plant containing less than 0.3% THC (tetrahydrocannabinol), which is the psychoactive component of the cannabis plant. After 40 years of prohibition, the Agricultural Improvement Act of 2018, known as the 2018 Farm Bill, legalized hemp at the federal level. Hemp production will be regulated by the United States Department of Agriculture (USDA) and the states. As a result, in 2019 hemp was generally removed from the Controlled Substances Act (CSA) and enforcement by the Drug Enforcement Administration (DEA).

For more information about Exactus: .

Investor Notice

Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks, uncertainties and forward-looking statements described under "Risk Factors" in Item 1A of our most recent Form 10-K for the fiscal year ended December 31, 2018 filed with the Securities and Exchange Commission (the "SEC") on March 29, 2019, and in other periodic and current reports we file with the SEC. If any of these risks were to occur, our business, financial condition, or results of operations would likely suffer. In that event, the value of our securities could decline, and you could lose part or all of your investment. The risks and uncertainties we describe are not the only ones facing us. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. In addition, our past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results in the future. See "Safe Harbor" below.

Safe Harbor - Forward-Looking Statements

The information provided in this press release may include forward-looking statements relating to future events or the future financial performance of the Company. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "anticipates," "plans," "expects," "intends," "will," "potential," "hope" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon current expectations of the Company and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release relating to the Company may be found in the Company's periodic and current filings with the SEC, including the factors described in the sections entitled "Risk Factors", copies of which may be obtained from the SEC's website at Any forward-looking statement speaks only as of the date on which such statement is made, and the Company does not intend to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise.

Company Contact:

Andrew Johnson

Chief Strategy Officer

Exactus Inc.

509-999-9695

EN
28/08/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Exactus Inc

 PRESS RELEASE

Exactus, Inc. Reports Second Quarter 2020 Financial Results and Confer...

Exactus, Inc. Reports Second Quarter 2020 Financial Results and Conference Call Second Quarter 2020 Highlights Total Net Revenue of $531,240Continuation of Sales & Marketing BuildoutWhite Label Division LaunchEuropean Sales ExpansionStrengthened the Balance Sheet DELRAY BEACH, Fla., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, reported its financial results for the second quarter 2020 and conference call dial-in information. During the second quarter of 2020, Exactus c...

 PRESS RELEASE

Exactus, Inc. Reports First Quarter 2020 Financial Results

Exactus, Inc. Reports First Quarter 2020 Financial Results First Quarter 2020 Highlights Total Net Revenue of $836,000Continuation of Sales & Marketing BuildoutRestructuring of Company and Board of DirectorsBegan Biomass Inventory Extraction ProcessDuring Q2 2020, The Company Received PPP Funds and an SBA Loan DELRAY BEACH, Fla., July 01, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, today reported financial results for the first quarter 2020. During the first quarter of 2020, E...

 PRESS RELEASE

Exactus Appoints Leading Business Expert, Julian Pittam to Chairman of...

Exactus Appoints Leading Business Expert, Julian Pittam to Chairman of the Board of Directors DELRAY BEACH, Fla., June 15, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the appointment of executive business leader, Julian Pittam to the Chairman of the Board. “Julian Pittam has been an investor and a friendly voice of wisdom since our inception, and we are honored to have him join as Chairman of the Board at this pivotal moment,” said Emiliano Aloi, Exactus Interim Chie...

 PRESS RELEASE

Exactus Announces its Hemp Seed Buyback Program to Assist Farmers Impa...

Exactus Announces its Hemp Seed Buyback Program to Assist Farmers Impacted by the COVID-19 Pandemic DELRAY BEACH, Fla., May 28, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the institution of its Exactus Hemp Buyback Program in support of farmers who purchase seeds from the company. Exactus introduced its buyback program during this essential hemp planting season to aid farmers faced with hardships caused by the COVID-19 pandemic. With the launch of its buyback progra...

 PRESS RELEASE

Exactus, Inc. Reports 2019 Year End Results

Exactus, Inc. Reports 2019 Year End Results Year End 2019 Highlights Completed first harvestEntered into multiple supply agreements with industry leadersBuilt a foundation for mainstream adoptionSolidified our footprint in the hemp industryDuring Q1 2020, purchase orders for approximately $900,000 of CBD and CBG products have been received. DELRAY BEACH, Fla., May 26, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, today reported financial results for the year end 2019. Duri...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch